Pharma Stability: Insights, Guidelines, and Expertise
SOP for Implementing Stability Testing for Pediatric Formulations under US FDA and EMA Guidelines Procedure for Stability Studies of Pediatric Drug Formulations According to US FDA and EMA Guidelines 1) Purpose The purpose of this SOP is to outline the procedure for conducting stability testing for pediatric drug formulations in accordance with US FDA and…
SOP for Preparing Stability Data for Compliance with FDA’s Quality by Design (QbD) Approach Procedure for Preparing Stability Data in Accordance with QbD Principles 1) Purpose The purpose of this SOP is to define a procedure for preparing stability data in compliance with the US FDA’s Quality by Design (QbD) approach. This ensures that stability…
SOP for Conducting Stability Studies for Dermatological Products in Compliance with Regulatory Guidelines Procedure for Stability Testing of Dermatological Products 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability studies for dermatological products in compliance with relevant regulatory guidelines. This ensures that these products maintain their quality, safety, and…
SOP for Implementing Stability Studies for Drug Products in Multi-Layered Packaging under Regulatory Guidelines Procedure for Stability Testing of Drug Products in Multi-Layered Packaging 1) Purpose The purpose of this SOP is to define a procedure for conducting stability studies for drug products in multi-layered packaging in compliance with relevant regulatory guidelines. This ensures that…
SOP for Addressing Stability Testing for Combination Antiretroviral Therapy (cART) under Regulatory Guidelines Procedure for Stability Testing of Combination Antiretroviral Therapy (cART) 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing for combination antiretroviral therapy (cART) in compliance with relevant regulatory guidelines. This ensures that cART products maintain…
SOP for Conducting Stability Testing for Biosimilars in Compliance with WHO Guidelines Procedure for Stability Testing of Biosimilars 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing for biosimilar products in compliance with the World Health Organization (WHO) guidelines. This ensures that biosimilars maintain their quality, safety, and…
Read More “SOP for Conducting Stability Testing for Biosimilars in Compliance with WHO Guidelines” »
SOP for Implementing Stability Testing for Pediatric Formulations under US FDA and EMA Guidelines Procedure for Stability Testing of Pediatric Formulations 1) Purpose The purpose of this SOP is to define the procedures for conducting stability testing for pediatric formulations in compliance with US FDA and EMA guidelines. This ensures that pediatric formulations maintain their…
SOP for Conducting Stability Studies for Drug Products Stored at Subzero Temperatures under Regulatory Guidelines Procedure for Stability Testing of Drug Products Stored at Subzero Temperatures 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability studies for drug products stored at subzero temperatures in compliance with relevant regulatory guidelines….
SOP for Implementing Stability Testing for Polymorphic Drug Substances under Regulatory Guidelines Procedure for Stability Testing of Polymorphic Drug Substances 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing for polymorphic drug substances in compliance with relevant regulatory guidelines. This ensures that polymorphic substances maintain their intended form,…
SOP for Addressing Stability Testing Requirements for Global Harmonization under ICH Guidelines Procedure for Stability Testing for Global Harmonization 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing to meet global harmonization requirements as outlined by the International Council for Harmonisation (ICH) guidelines. This ensures that drug products…